ストックスクリーナーアプリを入手
39.00
0.28%
-0.11
アフターアワーズ：
39.00
前日終値:
$39.11
開ける：
$39
24時間の取引高:
6.48M
Relative Volume:
9.08
時価総額：
$2.62B
収益：
-
当期純損益:
$-64.16M
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
$-69.06M
1週間 パフォーマンス:
+12.07%
1か月 パフォーマンス:
+9.95%
6か月 パフォーマンス:
-0.13%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$37.97
$39.23
1週間の範囲:
$34.71
$39.63
52週間の値動き範囲:
$25.77
$50.23
Cg Oncology Inc Stock (CGON) Company Profile
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-14 | 開始されました | H.C. Wainwright | Buy |
Cg Oncology Inc (CGON) 最新ニュース
Selling Buzz: Cg Oncology Inc. [CGON] Director Song Hong Fang sells 650,455 shares of the company - Knox Daily
Wilson Sonsini Advises GC Therapeutics on $65 Million Series A - Wilson Sonsini
Waterloo Capital L.P. Purchases 1,517 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Corning’s stock rises as it sticks to Q3 profit view - MarketWatch
Compugen Ltd. (NASDAQ:CGEN) Short Interest Update - Defense World
CGN Resources Ltd. Options Cease Amid Unmet Conditions - TipRanks
Cognyte Software (NASDAQ:CGNT) Lifted to “Strong-Buy” at StockNews.com - Defense World
Canadian General Investments (TSE:CGI) Share Price Passes Above 50 Day Moving Average of $38.48 - MarketBeat
Why is the Cochlear share price in the red today? - The Motley Fool Australia
Calamos Global Total Return Fund (NASDAQ:CGO) Short Interest Update - Defense World
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.1% - Defense World
Adversity is less terrifying than hope: Cg Oncology Inc. (CGON) - SETE News
(CGO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long - Business Wire
Compugen Ltd. (NASDAQ:CGEN) Short Interest Down 5.8% in August - MarketBeat
Coherus shares stumble on supply issue - The Pharma Letter
Quest Partners LLC Acquires New Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
HC Wainwright Reiterates Buy Rating for CG Oncology (NASDAQ:CGON) - MarketBeat
Analyst supports Buy rating on CG Oncology shares, focusing on differentiated safety profile - Investing.com Canada
CG Oncology, Inc. (NASDAQ:CGON) Short Interest Down 11.2% in August - MarketBeat
After-hours movers: Intuitive Machines, Casella Waste Systems, Galmed Pharma, Edgewise Therapeutics - Investing.com South Africa
Do investors need to be concerned about Cg Oncology Inc. (CGON)? - US Post News
Cogent Biosciences Inc (COGT) stock analysis: A comprehensive overview - US Post News
Coherus Biosciences Inc (CHRS) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Coherus BioSciences, Inc. (NASDAQ:CHRS) Has Found A Path To Profitability - Simply Wall St
The battle brewing over blood tests for cancer | Today News - Mint
Cg Oncology Inc. (CGON) Stock: A Comprehensive 52-Week Review - The InvestChronicle
The Battle Brewing Over Blood Tests for Cancer - The Wall Street Journal
Analyzing Cg Oncology Inc. (CGON) After Recent Trading Activity - Knox Daily
CG Oncology (NASDAQ:CGON) Trading 4.6% Higher - MarketBeat
CG Oncology surges 7%; seen benefitting from J&J bladder cancer asset data - MSN
CG Oncology, Inc. (NASDAQ:CGON) Shares Acquired by Bank of New York Mellon Corp - MarketBeat
CG Oncology surges 7%; seen benefitting from J&J bladder cancer asset data - Seeking Alpha
Is Cogent Biosciences Inc (COGT) positioned for future growth? - SETE News
Quarterly Metrics: Quick and Current Ratios for Cogent Biosciences Inc (COGT) - The Dwinnex
Stock Market Recap: Cg Oncology Inc. (CGON) Concludes at 34.80, a -0.09 Surge/Decline - The Dwinnex
CG Oncology shares: Goldman Sachs reiterates Buy, cites limited downside amid new data - Investing.com Canada
Cg Oncology Inc. (CGON): Short Seller Sentiment is Bearish on This Cancer Stock - Insider Monkey
Cg Oncology Inc. (CGON): Short Seller Sentiment is Bearish on This Cancer Stock - Yahoo Finance
TD Asset Management Inc Purchases Shares of 93,084 CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
A company insider recently sold 650,455 shares of Cg Oncology Inc. [CGON]. Should You Sale? - Knox Daily
Cg Oncology Inc. (CGON)’s results reveal risk - US Post News
CG Oncology (NASDAQ:CGON) Stock Price Down 3.6% - MarketBeat
10 Worst Cancer Stocks To Buy Now According to Short Sellers - Insider Monkey
Market Highlights: Cg Oncology Inc. (CGON) Ends on a Low Note at 36.12 - The Dwinnex
CGON: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Cg Oncology Inc. [CGON] Stock sold by Insider Song Hong Fang for $23.0 million - Knox Daily
Perhaps timely catching Cg Oncology Inc. (CGON) would be a good idea - SETE News
Cg Oncology Inc. [CGON] stock for 23,000,089 USD was sold by Song Hong Fang - Knox Daily
There is no doubt that Cg Oncology Inc. (CGON) ticks all the boxes. - SETE News
CG Oncology, Inc. (NASDAQ:CGON) Director Sells $23,000,088.80 in Stock - MarketBeat
Cg Oncology Inc (CGON) 財務データ
収益
当期純利益
現金流量
EPS
3.59%
5.31%
大文字化:
|
ボリューム (24 時間):